A Study of NGM282 in Patients With Primary Sclerosing Cholangitis
Clinical trial NCT02704364 · COMPLETED
Trial details
- NCT number
- NCT02704364
- Sponsor
- NGM Biopharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2017-06-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.